Gomes Rafael Kmiliauskis Santos, Pires Fabio Antero, Nobre Moacyr Roberto Cuce, Marchi Mauricio Felippi de Sá, Rickli Jennifer Cristina Kozechen
Centro de Especialidades do Município de Blumenau, Blumenau, SC, Brazil; Centro de Especialidades do Município de Brusque, Brusque, SC, Brazil.
Universidade de São Paulo (USP), Faculdade de Medicina, Unidade de Sistemas do Serviço de Informática, São Paulo, SP, Brazil.
Rev Bras Reumatol Engl Ed. 2017 May-Jun;57(3):204-209. doi: 10.1016/j.rbre.2016.07.003. Epub 2016 Oct 6.
There are few studies that carried out a descriptive and trend analysis based on available data from the Unified Health System (SUS) between pre- and post-free dispensing of pharmacological treatment of rheumatoid arthritis (RA) from the perspective of the public health system, in terms of the direct cost of the disease among adults and elderly residents of the State of Santa Catarina, Brazil. This study aims to characterize the direct cost of medical and surgical procedures before and after the dispensing of drugs in this state.
This is a time series-type study with a cross-sectional survey of data from the Hospital (SIH) and Outpatient (SIA) Information System of SUS during the period from 1996 to 2009.
Between 1996 and 2009, the total expenditure for hospital- and outpatient pharmacological treatment of rheumatoid arthritis was R$ 26,659,127.20. After the dispensing of drug treatment by SUS a decrease of 36% in the number of hospital admissions was observed; however, an increase of 19% in clinical procedures was noted.
During the observed period, a reduction in the number of hospital admissions for both clinical and orthopedic surgical procedures related to this disease was observed. Nevertheless, there was an increase in the cost of medical admissions.
从公共卫生系统的角度出发,基于巴西圣卡塔琳娜州成年和老年居民中类风湿关节炎(RA)药物治疗免费发放前后统一卫生系统(SUS)的现有数据,开展描述性和趋势分析的研究较少。本研究旨在描述该州药物发放前后医疗和外科手术的直接成本。
这是一项时间序列类型的研究,对1996年至2009年期间SUS的医院(SIH)和门诊(SIA)信息系统的数据进行横断面调查。
1996年至2009年期间,类风湿关节炎的医院和门诊药物治疗总支出为26,659,127.20雷亚尔。SUS发放药物治疗后,观察到住院人数减少了36%;然而,临床程序增加了19%。
在观察期内,观察到与该疾病相关的临床和骨科外科手术的住院人数有所减少。尽管如此,医疗住院成本有所增加。